Database Studies
We have experience working with over 30 different data sources to answer your HEOR questions to address your RWE and HEOR research questions
OXON conducts single-country and multinational database studies to generate robust real-world evidence that supports healthcare decision-making, drug safety, health economics and outcomes research (HEOR), market access and regulatory requirements.
Turning Real-World Data into actionable evidence
Our scientific and methodological expertise enables us to design and conduct database studies that address complex research questions, from treatment effectiveness and safety to disease burden, healthcare resource utilisation and patient outcomes. By combining global data source knowledge with expertise in pharmacoepidemiology, biostatistics and HEOR, OXON delivers reliable real-world evidence to support informed decisions throughout the product lifecycle.
DATABASE STUDIES
OXON performs single- and multi-database studies, collaborating with academic and commercial data providers across multiple countries.
Real-world healthcare databases, including electronic health records (EHR), administrative claims databases and national health registries, provide valuable information on treatment patterns, clinical outcomes, healthcare resource utilisation and patient populations.
We understand that selecting the most appropriate data source is essential to generating valid, reliable and scientifically rigorous evidence. Our experts assess database suitability based on the research objectives, population coverage, data availability, quality and fitness for purpose.
GLOBAL REAL-WORLD DATA SOURCES
We have experience working with over 40 real-world data sources worldwide, including:
EUROPE
France: SNDS
Germany: InGef, GePaRD
Israel: Clalit Health Services, MaccabiTech
Italy: Pedianet, HealthSearch
Netherlands: PHARMO
Nordic countries: SNPR, NPR, DNPR
Spain: VID, SIDIAP, IOMED (EHR data with natural language processing for unstructured clinical information)
United Kingdom: CPRD, THIN, HES and NCRAS
NORTH AMERICA
Canada: Discharge Abstract Database (DAD)
United States: MarketScan, Optum, StatinMed and Carelon
ASIA
China: Healthcare databases in Tianjin and Beijing
Japan: MDV, JMDC
South Korea: HIRA, NHID
DISEASE REGISTRIES
We also collaborate with disease-specific registries worldwide across multiple therapeutic areas, assessing each source for its suitability and fitness for purpose.